Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study (Q46682096)
Jump to navigation
Jump to search
scientific article published in February 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study |
scientific article published in February 2006 |
Statements
1 reference
Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study (English)
1 reference
W B London
1 reference
C K Tebbi
1 reference
N Mendenhall
1 reference
J L Williams
1 reference
P A de Alarcon
1 reference
A R Chauvenet
1 reference
Children's Oncology Group
1 reference
1 February 2006
1 reference
46
1 reference
2
1 reference
198-202
1 reference
Identifiers
1 reference